Behcet's syndrome
Last edited 01/2023 and last reviewed 10/2023
Behcet's syndrome is a systemic venulitis.
The aetiology of Behcet's disease is not fully understood, however, a combination of genetic and environmental factors may play a role (1):
- there is a strong HLA association with HLA-B51; this genetic marker is found in around 60% of BD patients (1)
- Herpes simplex virus-1 (HSV-1) and Streptococcus have been postulated as possible environmental triggers of BD (2)
International Study Group for Behcet's disease (ISG) criteria for the diagnosis of Behcet disease (1,2).
Recurrent oral ulceration |
Minor aphthous, major aphthous, or herpetiform ulcers observed by the physician or patient, which have recurred at least 3 times over a 12-month period |
Plus any 2 of the following: |
|
Recurrent genital ulceration |
Aphthous ulceration or scarring observed by the physician or patient |
Eye lesions |
Anterior uveitis, posterior uveitis, or cells in the vitreous on slit lamp examination; or retinal vasculitis detected by an ophthalmologist |
Skin lesions |
Erythema nodosum observed by the physician or patient, pseudofolliculitis, or papulopustular lesions; or acneiform nodules observed by the physician in a postadolescent patient who is not receiving corticosteroids |
Positive pathergy test |
Test interpreted as positive by the physician at 24-48 h |
The International Criteria for Behcet's disease (ICBD) was developed because of low sensitivity of ISG clinical diagnostic criteria (3).
The ICBD criteria are outlined below:
Sign/Symptom | Points |
Ocular lesions | 2 |
Genital aphthosis | 2 |
Oral aphthosis | 2 |
Skin lesions | 1 |
Neurological manifestations | 1 |
Vascular manifestations | 1 |
Positive pathergy test (a) | 1 |
(a) Pathergy test is optional. Where a pathergy test is conducted, 1 extra point may be added for a positive result
A patient scoring >= 4 points is classified as having Behcet's disease (3)
A study derived from multinational data showed that the ICBD criteria exhibits much improved sensitivity over the ISG criteria while maintaining reasonable specificity (3)
Reference:
- Nair JR, Moots RJ. Behcet's disease. Clin Med (Lond). 2017 Feb;17(1):71-77. Doi: 10.7861/clinmedicine.17-1-71. PMID: 28148585; PMCID: PMC6297594.
- Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, de Vincentiis M, Lambiase A. Behcet's disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018 Jun;17(6):567-575.
- International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD). The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. doi: 10.1111/jdv.12107. Epub 2013 Feb 26. PMID: 23441863